Event Details

January 01, 1784

Description

First publicly acknowledged placebo-controlled trial

Participants (3)

Name Type Mentions
Mesmer person 7 View Entity
King person 85 View Entity
Benjamin Franklin person 14 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_029926.jpg

Magazine Article (Evidence Exhibit) • 2.56 MB
View

This document is a scanned page (p. 31) from the December 12, 2011 issue of The New Yorker, bearing a House Oversight Bates stamp. The text discusses the science and history of the placebo effect, focusing on a researcher named Kaptchuk and historical instances involving Benjamin Franklin and Franz Anton Mesmer. While the document is stamped as part of a House Oversight investigation (likely related to Epstein's connections to scientific funding or MIT), the text on this specific page contains no direct mention of Jeffrey Epstein or his associates.

Related Events

Events with shared participants

Restructuring of the Saudi Cabinet and government bodies announced.

2016-01-01 • Saudi Arabia

View

The case United States v. King, where the Second Circuit upheld sealing parts of the record based on jurors' privacy interests.

Date unknown • United States

View

United States v. King, 560 F.2d 122, 130-31 (2d Cir. 1977)

1977-01-01 • 2d Cir.

View

Ruling in King v. United States, affirming the denial of a hearing where evidence was 'weakly authenticated, vague, and speculative'.

1978-01-01 • Second Circuit

View

Assassination of Martin Luther King Jr.

0004-04-01 • Memphis

View

Receipt of audio recording with Q&A; video recording expected mid-to-late afternoon.

2016-08-05 • N/A

View

King Salman's accession

2015-01-01 • Saudi Arabia

View

King Salman announced the King Salman Bridge to North Sinai.

Date unknown

View

Event Metadata

Type
Unknown
Location
France
Significance Score
5/10
Participants
3
Source Documents
1
Extracted
2025-11-19 23:05

Additional Data

Source
HOUSE_OVERSIGHT_029926.jpg
Date String
1784

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event